# Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)

> **NCT00727311** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 2302 (actual)

## Conditions studied

- Hepatitis C, Chronic
- Hepatitis C

## Interventions

- **BIOLOGICAL:** PegIntron (peginterferon alfa-2b; SCH 54031) injector
- **DRUG:** Rebetol (ribavirin; SCH 18908)

## Key facts

- **NCT ID:** NCT00727311
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 2302 (ACTUAL)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00727311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00727311, "Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00727311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*